Stock

Metagenomi Therapeutics, Inc. MGX

$1.21-1.23%

All stocks Create account to unlock

Overview

MGX market data

Price History

MGX price chart

Valuation & Profitability

no valuation data

No Valuation Data Yet

Alpha Vantage and Twelve Data both returned no valuation metrics for MGX. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.

Company news

3 captured

Chardan Capital Maintains Buy on Metagenomi Therapeutics, Lowers Price Target to $5 · Jul 7, 2026, 11:05 AM

8-K filing — Metagenomi Therapeutics, Inc. (MGX) · Jun 9, 2026, 10:11 PM

Hemophilia Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight · May 5, 2026, 5:10 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock